The most advanced cell therapy infrastructure in the Baltic region is being developed in Vilnius. Global biotechnology leader Northway Biotech is completing the construction of a new Innovative Cell Therapy and Personalized Medicine Center in the Vilnius City Innovation Industrial Park (VCIIP). Covering an area of 3,500 square meters, the center is being built by the Stem Cell Research Center, a company belonging to the Northway group of companies. Investment in the new center amounts to €61 million. It is planned that the center will employ around 100 highly qualified specialists in biotechnology, bioengineering, molecular biology, and other life sciences fields.